tetradecanoylphorbol acetate has been researched along with Cardiovascular Stroke in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 8 (40.00) | 18.2507 |
| 2000's | 9 (45.00) | 29.6817 |
| 2010's | 2 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandra, M; Day, A; Maxey, B; Miriyala, S; Panchatcharam, M; St Clair, DK | 1 |
| Han, LP; Li, H; Li, HZ; Li, WM; Lin, Y; Sun, YH; Tian, Y; Wang, LN; Wang, R; Xu, CQ; Yang, BF; Zhang, L; Zhang, WH; Zhao, YJ | 1 |
| Cha, MJ; Chang, W; Choi, E; Choi, EJ; Ham, O; Hwang, HJ; Hwang, KC; Jang, Y; Kim, IK; Kim, SH; Lee, C; Lee, CY; Lee, M; Lee, MH; Lee, SY; Lim, S; Park, JH; Song, BW; Song, H | 1 |
| Backx, PH; Batthish, M; Diaz, RJ; Wilson, GJ; Zeng, HP | 1 |
| Ikeda, U; Maeda, Y; Shimada, K; Yamamoto, K | 1 |
| Ito, H; Kinoshita, M; Matsumori, A; Nakano, A | 1 |
| Caimi, G; Canino, B; Casciolo, MF; Catania, A; Dispensa, F; Hoffmann, E; Incalcaterra, E; Lo Presti, R; Montana, M | 1 |
| Akatsu, T; Hiramori, K; Nakamura, M; Satoh, M; Shimoda, Y | 1 |
| Cohen, MV; Cui, L; Davis, AM; Downey, JM; Philipp, S; Yang, XM | 1 |
| Albrecht, B; Cohen, MV; Critz, SD; Cui, L; Downey, JM; Krahn, T; Kuno, A; Philipp, S; Solodushko, V; Yang, XM | 1 |
| Goto, M; Iimura, O; Miura, T; Sakamoto, J | 1 |
| Hori, M; Inoue, M; Kamada, T; Kitakaze, M; Minamino, T; Node, K; Tada, M | 1 |
| Galkop, S; Katz, A; Levy, R; Riesenberg, K; Schlaeffer, F | 1 |
| Baines, CP; Cohen, MV; Downey, JM; Wang, L | 1 |
| Asakura, M; Asanuma, H; Hori, M; Kitakaze, M; Kuzuya, T; Mori, H; Node, K; Sakata, Y; Sanada, S; Shinozaki, Y; Takashima, S | 1 |
| Cho-Chung, YS; Lee, YN; Park, YG | 1 |
| Fein, AM; Grant, MM; Kantrowitz, N; Niederman, MS | 1 |
| Brown, R; Mousa, SA; Smith, RD; Thoolen, MJ | 1 |
| Branzi, A; Caldarera, I; Guarnieri, C; Guizzardi, S; Ligabue, A; Melandri, G; Scheda, M | 1 |
| Caplan, M; Hess, ML; Lucchesi, B; Romson, JL; Rowe, GT | 1 |
1 review(s) available for tetradecanoylphorbol acetate and Cardiovascular Stroke
| Article | Year |
|---|---|
Oligonucleotides as transcription factor decoys.
Topics: Angioplasty, Balloon, Coronary; Cell Adhesion; Cell Cycle Proteins; Cell Nucleus; Coronary Stenosis; Cyclic AMP; DNA; DNA-Binding Proteins; Drug Design; Drug Stability; E2F Transcription Factors; Enhancer Elements, Genetic; Gene Expression Regulation; Gene Products, tat; Genes, rev; Genes, tat; Glomerulonephritis; HIV Reverse Transcriptase; Myocardial Infarction; NF-kappa B; Nucleic Acid Conformation; Oligodeoxyribonucleotides; Promoter Regions, Genetic; Protein Binding; Recurrence; Regulatory Sequences, Nucleic Acid; Reverse Transcriptase Inhibitors; Second Messenger Systems; Structure-Activity Relationship; Substrate Specificity; Tetradecanoylphorbol Acetate; Thionucleotides; Transcription Factors; Tunica Intima | 1999 |
19 other study(ies) available for tetradecanoylphorbol acetate and Cardiovascular Stroke
| Article | Year |
|---|---|
Arjunolic acid ameliorates reactive oxygen species via inhibition of p47(phox)-serine phosphorylation and mitochondrial dysfunction.
Topics: Animals; Antioxidants; Disease Models, Animal; Gene Expression Regulation; Glycolysis; Humans; Lysosomes; Male; Mice; Mitochondria; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Infarction; NADPH Oxidases; Neutrophils; Oxidative Phosphorylation; Oxidative Stress; Phosphorylation; Primary Cell Culture; Signal Transduction; Superoxides; Tetradecanoylphorbol Acetate; Triterpenes | 2015 |
Involvement of the ornithine decarboxylase/polyamine system in precondition-induced cardioprotection through an interaction with PKC in rat hearts.
Topics: Animals; Apoptosis; Blotting, Western; Heart; In Situ Nick-End Labeling; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Ornithine Decarboxylase; Polyamines; Protein Kinase C; Rats; Rats, Wistar; Subcellular Fractions; Tetradecanoylphorbol Acetate | 2009 |
Cardiomyocytes from phorbol myristate acetate-activated mesenchymal stem cells restore electromechanical function in infarcted rat hearts.
Topics: Analysis of Variance; Animals; Blotting, Western; Cell- and Tissue-Based Therapy; Connexin 43; Cytokines; Electrocardiography; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; In Situ Nick-End Labeling; Isoproterenol; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardial Contraction; Myocardial Infarction; Myocytes, Cardiac; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic; Reverse Transcriptase Polymerase Chain Reaction; Tetradecanoylphorbol Acetate | 2011 |
Pharmacological preconditioning in rabbit myocardium is blocked by chloride channel inhibition.
Topics: Adenosine; Animals; Cells, Cultured; Chloride Channels; Dose-Response Relationship, Drug; Enzyme Activators; Glycolates; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Myocardium; Perfusion; Protein Kinase C; Rabbits; Receptors, Purinergic P1; Tetradecanoylphorbol Acetate | 2002 |
C-Reactive protein augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes.
Topics: Animals; C-Reactive Protein; Cardiomyopathy, Dilated; Cells, Cultured; Enzyme Inhibitors; Humans; Interleukin-1; Myocardial Infarction; Myocytes, Cardiac; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Protein Kinase C; Rats; Rats, Sprague-Dawley; Recombinant Proteins; RNA, Messenger; Tetradecanoylphorbol Acetate | 2002 |
Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia/reperfusion injury in a rat model.
Topics: Animals; Chemokine CCL2; Disease Models, Animal; Hypoglycemic Agents; Intercellular Adhesion Molecule-1; Macrophage Activation; Macrophages; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Pioglitazone; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Tetradecanoylphorbol Acetate; Thiazolidinediones; Transcription Factors | 2003 |
Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca(2+) content in young adults with acute myocardial infarction. Evaluation at the initial stage and after 12 months.
Topics: Adult; Calcium; Cell Membrane; Cytosol; Fluorescent Dyes; Follow-Up Studies; Humans; Leukocyte Count; Male; Membrane Fluidity; Myocardial Infarction; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Tetradecanoylphorbol Acetate; Time Factors | 2004 |
Activated tumour necrosis factor-alpha shedding process is associated with in-hospital complication in patients with acute myocardial infarction.
Topics: ADAM Proteins; ADAM17 Protein; Aged; Arrhythmias, Cardiac; Cells, Cultured; Female; Heart Failure; Humans; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Metalloendopeptidases; Middle Aged; Myocardial Infarction; Prognosis; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2005 |
Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade.
Topics: Acetamides; Adenosine; Adenosine A2 Receptor Antagonists; Adenosine-5'-(N-ethylcarboxamide); Alkaloids; Androstadienes; Animals; Aorta; Benzophenanthridines; Constriction; Enzyme Activators; Female; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Perfusion; Phenanthridines; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase C; Purines; Rabbits; Receptor, Adenosine A2B; Signal Transduction; Tetradecanoylphorbol Acetate; Wortmannin; Xanthines | 2006 |
Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion.
Topics: Acetamides; Adenosine A2 Receptor Agonists; Adenosine-5'-(N-ethylcarboxamide); Alkaloids; Aminopyridines; Animals; Benzophenanthridines; Ischemic Preconditioning, Myocardial; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Infarction; Myocardial Reperfusion Injury; Perfusion; Phosphorylation; Protein Kinase C; Purines; Rabbits; Receptor, Adenosine A2B; Signal Transduction; Tetradecanoylphorbol Acetate | 2007 |
Limitation of myocardial infarct size by adenosine A1 receptor activation is abolished by protein kinase C inhibitors in the rabbit.
Topics: Alkaloids; Animals; Dose-Response Relationship, Drug; Male; Myocardial Infarction; Myocardium; Phenylisopropyladenosine; Polymyxin B; Protein Kinase C; Rabbits; Staurosporine; Stimulation, Chemical; Tetradecanoylphorbol Acetate | 1995 |
Activation of ecto-5'-nucleotidase by protein kinase C and its role in ischaemic tolerance in the canine heart.
Topics: 5'-Nucleotidase; Animals; Dogs; Enzyme Activation; Female; Hemodynamics; Indoles; Ischemic Preconditioning; Male; Maleimides; Myocardial Infarction; Myocardial Ischemia; Phosphorylation; Protein Kinase C; Tetradecanoylphorbol Acetate | 1997 |
Neutrophil superoxide release and interleukin 8 in acute myocardial infarction: distinction between complicated and uncomplicated states.
Topics: Aged; Aged, 80 and over; Female; Humans; Interleukin-8; Male; Middle Aged; Myocardial Infarction; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Ozone; Streptokinase; Superoxides; Tetradecanoylphorbol Acetate | 1997 |
Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart.
Topics: Alkaloids; Animals; Anisomycin; Benzophenanthridines; Enzyme Activation; Enzyme Inhibitors; Female; Genistein; Hemodynamics; Ischemic Preconditioning, Myocardial; Male; Mitogen-Activated Protein Kinase Kinases; Myocardial Infarction; Myocardial Reperfusion Injury; Phenanthridines; Phenols; Protein Kinase C; Protein Kinases; Protein-Tyrosine Kinases; Rabbits; Signal Transduction; Tetradecanoylphorbol Acetate | 1998 |
Protein tyrosine kinase is not involved in the infarct size-limiting effect of ischemic preconditioning in canine hearts.
Topics: 5'-Nucleotidase; Animals; Carcinogens; Dogs; Enzyme Activation; Enzyme Inhibitors; Genistein; Ischemic Preconditioning; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Phenols; Protein Kinase C; src-Family Kinases; Tetradecanoylphorbol Acetate | 2000 |
Neutrophil-endothelial cell interaction in critical illness.
Topics: Aged; Cell Adhesion; Cells, Cultured; Endothelium, Vascular; Female; Humans; Infections; Male; Myocardial Infarction; Neutrophils; Prospective Studies; Respiratory Distress Syndrome; Tetradecanoylphorbol Acetate | 1991 |
Evaluation of the effect of azapropazone on neutrophil migration in regional myocardial ischaemia/reperfusion injury in rabbits.
Topics: Animals; Apazone; Blood Pressure; Cell Migration Inhibition; Coronary Disease; Coronary Vessels; Heart Rate; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Neutrophils; Peroxidase; Rabbits; Tetradecanoylphorbol Acetate; Triazines | 1990 |
Reduced oxidative activity of circulating neutrophils in patients after myocardial infarction.
Topics: Aged; Humans; Middle Aged; Myocardial Infarction; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxidation-Reduction; Tetradecanoylphorbol Acetate; Time Factors | 1990 |
Identification of hydrogen peroxide and hydroxyl radicals as mediators of leukocyte-induced myocardial dysfunction. Limitation of infarct size with neutrophil inhibition and depletion.
Topics: Adenosine Triphosphatases; Animals; Butylated Hydroxytoluene; Calcium; Catalase; Dogs; Free Radicals; Hydrogen Peroxide; Hydroxides; Hydroxyl Radical; Ibuprofen; Indomethacin; Leukocytes; Male; Mannitol; Myocardial Infarction; Myocardium; Neutrophils; Sarcoplasmic Reticulum; Superoxide Dismutase; Tetradecanoylphorbol Acetate | 1985 |